Horseshoe kidney AAA

Aug 30, 2006

A volume-rendered 360° rotation series showing a preop abdominal aortic aneurysm (AAA) patient with a horseshoe kidney and multiple renal arteries bilateraly.

none
Latest in Genitourinary Radiology
Ultrasound Probe2 400
Microultrasound could be alternative to MRI for prostate biopsy
March 26, 2025
Prostate Imaging2
Quibim’s QP-Prostate cleared for diagnosing prostate cancer
March 21, 2025
Elevate your patient's care with the capabilities of Cardiac PET/CT
Sponsored
Elevate your patient's care with the capabilities of Cardiac PET/CT
March 1, 2025
MRI scans show two areas of clinically significant prostate cancer in a 65-year-old man with a prostate-specific antigen level of 8.23 ng/mL. Images are (A, E) axial T2-weighted images, (B, F) axial diffusion-weighted images obtained with a b value of 1500 sec/mm2, (C, G) axial apparent diffusion coefficient images, and (D, H) lesion masks generated by the deep learning algorithm (DLA) on T2-weighted images. The DLA detected a lesion in the right posteromedial peripheral zone of the apex (D), which was assigned as Prostate Imaging Reporting and Data System (PI-RADS) 4. A radiologist also detected the lesion and assigned it PI-RADS 4 (arrow in A-C). A lesion in the right anterior transition zone (H) was detected by the DLA, which was assigned PI-RADS 4. The radiologist did not detect the lesion (arrow in E-G). Both lesions were confirmed as prostate cancer with Gleason grade group 2. Caption and image courtesy of RSNA.
DL algorithm targeting prostate cancer demonstrates clinical impact
March 12, 2025
More in Genitourinary Radiology
Microultrasound could be alternative to MRI for prostate biopsy
By Amerigo Allegretto
Microultrasound may be a suitable alternative to MRI for image-guided prostate biopsy.
March 26, 2025
Ultrasound Probe2 400
Quibim’s QP-Prostate cleared for diagnosing prostate cancer
By AuntMinnie.com staff writers
Quibim has received clearance from the U.S. Food and Drug Administration (FDA) for use of its QP-Prostate MRI software to help detect and diagnose prostate cancer.
March 21, 2025
Prostate Imaging2
FDA greenlights Telix NDA for prostate imaging agent Gozellix
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has approved a new drug application (NDA) for Telix's TLX007-CDx for prostate cancer imaging.
March 21, 2025
Fda Logo V2 Social
DL algorithm targeting prostate cancer demonstrates clinical impact
By Liz Carey
Per participant, a deep-learning (DL) algorithm demonstrated increased specificity of 64.8% compared with radiologists at 21.3%.
March 12, 2025
MRI scans show two areas of clinically significant prostate cancer in a 65-year-old man with a prostate-specific antigen level of 8.23 ng/mL. Images are (A, E) axial T2-weighted images, (B, F) axial diffusion-weighted images obtained with a b value of 1500 sec/mm2, (C, G) axial apparent diffusion coefficient images, and (D, H) lesion masks generated by the deep learning algorithm (DLA) on T2-weighted images. The DLA detected a lesion in the right posteromedial peripheral zone of the apex (D), which was assigned as Prostate Imaging Reporting and Data System (PI-RADS) 4. A radiologist also detected the lesion and assigned it PI-RADS 4 (arrow in A-C). A lesion in the right anterior transition zone (H) was detected by the DLA, which was assigned PI-RADS 4. The radiologist did not detect the lesion (arrow in E-G). Both lesions were confirmed as prostate cancer with Gleason grade group 2. Caption and image courtesy of RSNA.
bpMRI, mpMRI show comparable NPV for prostate cancer
By Kate Madden Yee
Biparametric MRI (bpMRI) and multiparametric MRI (mpMRI) show similar negative predictive value (NPV) in identifying prostate cancer.
March 7, 2025
Prostate Cancer 3 D Rendering
AI model aimed at adrenal glands, nodules could reduce workload by 10%
By Liz Carey
A future vision of AI in this context could entail analyzing adrenal nodules across multiple phases, extracting radiomic data, and providing a predictability score, study authors said.
March 4, 2025
Images Large Radiol Thumbnail
Doctors discuss prostate cancer imaging pressure points
By Liz Carey
If MRI prostagram proves to be a good screening tool for prostate cancer, urologists are going to have a lot of work on their hands, according to a talk at ECR 2025.
March 3, 2025
Benign Prostatic Hyperplasia
Ultrasound falls short for detecting endometrial cancer in Black women
By Amerigo Allegretto
Ultrasound-based strategies fall short of biopsy for detecting endometrial cancer in non-Hispanic Black women.
February 21, 2025
Ultrasound Diagnostic Control Panel 400
Deep learning plus CT imaging can assess incidental kidney masses
By Kate Madden Yee
Deep-learning models can noninvasively predict the likelihood of malignant and aggressive pathology of incidentally discovered renal masses based on preoperative CT images.
February 7, 2025
Kidney
Use of PCCT with gadoxetate disodium shows promise for liver imaging
By Kate Madden Yee
Using photon-counting CT (PCCT) with the gadolinium-based contrast agent gadoxetate disodium shows promise for improved liver visualization at a lower dose than is required for CT exams using other GBCA agents.
February 6, 2025
2025 02 06 Thumbnail Image Of Gadoxetate Disodium Dilution Series From Custom Phantom Thumbnail
Volume of AI-segmented lesions predicts prostate cancer outcomes
By Kate Madden Yee
An AI method for measuring prostate tumor volume based on multiparametric MRI (mpMRI) data shows promise for predicting treatment outcomes.
October 30, 2024
Yang Image Thumbnail
Dedicated ultrasound, MRI protocols improve endometriosis diagnosis
By Kate Madden Yee
Dedicated ultrasound and MRI protocols -- in contrast to routine ones -- are more effective in diagnosing endometriosis, researchers have reported.
September 13, 2024
Ultrasound Transducer3
Page 1 of 92
Next Page